SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Heart (CAMH)-What is this???

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Perry who wrote (16)3/19/1997 11:18:00 PM
From: John Zwiener   of 33
 
Hi James, just a little news on CAMH. No specific numbers, but from the tone of it , this seems to be the same kind of supporting findings that have been previously published. Things seem to be on track.
biz.yahoo.com

Rumors about IGEN. Just general stuff like we talked about before. Should be over 1000 of the 2010's out there, the hope is for over 3000 by end of year. The 1010 instrument will supposed to be placed in a similar number of places, though I guess I still haven't accepted that high number yet( by end of year-maybe I misunderstood). Other deals-well we've speculated about that before.

Another, Cytyc (CYTC), this thinprep seems to be catching on. An improved pap test (not smear). I still have not fiqured out how to value this one, but I've had it for a while and I'm guessing until I get more reliable info for evaluating the potential.. I think the thinprep will replace the pap smear.

Anothe, Neopath (NPTH), this is an automated screener for pap tests. It seems to be more reliable than screening by a cytotech. Combined with the thinprep, it catches 95% of low grade abnormalities and 100% of high grades. It just was approved as the PRIMARY screener for pap tests in Japan.

Later
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext